Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, Mathias Grunke, Joerg Henes, Ina Kötter, Judith Haas, Leonore Unger, Svjetlana Lovric, Marion Haubitz, Rebecca Fischer-Betz, Gamal Chehab, Andrea Rubbert-Roth, Christof Specker, Jutta Weinerth, Julia Holle, Ulf Müller-Ladner, Ramona König, Christoph Fiehn, Philip BurgwinkelKlemens Budde, Helmut Sörensen, Michael Meurer, Martin Aringer, Bernd Kieseier, Cornelia Erfurt-Berge, Michael Sticherling, Roland Veelken, Ulf Ziemann, Frank Strutz, Praxis von Wussow, Florian M P Meier, Nico Hunzelmann, Enno Schmidt, Raoul Bergner, Andreas Schwarting, Rüdiger Eming, Michael Hertl, Rudolf Stadler, Michael Schwarz-Eywill, Siegfried Wassenberg, Martin Fleck, Claudia Metzler, Uwe Zettl, Jens Westphal, Stefan Heitmann, Anna L Herzog, Heinz Wiendl, Waltraud Jakob, Elvira Schmidt, Klaus Freivogel, Thomas Dörner

Research output: Contribution to journalOriginal Articlepeer-review

157 Citations (Web of Science)
Original languageEnglish
Pages (from-to)R75
JournalARTHRITIS RESEARCH AND THERAPY
Volume13
Issue number3
DOIs
Publication statusPublished - 2011

Keywords

  • SYSTEMIC-LUPUS-ERYTHEMATOSUS
  • B-CELL DEPLETION
  • REFRACTORY WEGENERS-GRANULOMATOSIS
  • ANTIBODY-ASSOCIATED VASCULITIS
  • ACTIVE RHEUMATOID-ARTHRITIS
  • PROGRESSIVE MULTIPLE-SCLEROSIS
  • DOUBLE-BLIND
  • MIXED CRYOGLOBULINEMIA
  • ANKYLOSING-SPONDYLITIS
  • LYMPHOCYTE DEPLETION

Cite this